Top Markets
#1 Akedo Akedo +195.32%
#2 ONFA ONFA +54.15%
#3 Talus Network Talus Network +27.78%
#4 Osaka Protocol Osaka Protocol +21.37%
#5 0G 0G +21.23%
#6 Metaplex Metaplex +20.26%
#7 Wrapped Krown Wrapped Krown +19.97%
#8 EVAA Protocol EVAA Protocol +18.16%
#9 eCash eCash +16.58%
#10 Unibase Unibase +14.63%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
Classifica tra le azioni #146
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Prezzo delle azioni
$24.25
Capitalizzazione di mercato
$138.21B
Variazione (1 giorno)
-0.94%
Variazione (1 anno)
194.85%
Paese
US
Scambia Pfizer Inc. (PFE)

Categoria

Healthcare
Ricavi di Pfizer Inc. (PFE)
Ricavi nel Jul 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Pfizer Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Pfizer Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 $72.25B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $96.36B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $62.82B -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $65.59B -
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 $56.05B -
CH